Correctional Services - Medication Review Committee - Administration of Psychotropic Medication to an Incarcerated Individual
Summary
HB779 authorizes the Department of Public Safety and Correctional Services to establish a medication review committee to evaluate whether psychotropic medication may be administered to an incarcerated individual who refuses it. The bill applies only to State correctional facilities and generally prohibits administering psychotropic medication over objection except in an emergency, or in a nonemergency when a treating practitioner recommends involuntary treatment and a committee approves it after reviewing the clinical record and hearing from the incarcerated individual and other participants.
The bill sets out detailed procedures for the committee’s composition, notice requirements, the incarcerated individual’s rights, the medical information that must be provided, and the standards the committee must use in deciding whether medication is clinically justified. It also creates an administrative review process by the Clinical Services Management Team, allows limited stays of initial decisions, limits approvals to 90 days, permits renewal reviews, and requires ongoing documentation by the treating physician of benefits and side effects. The act takes effect October 1, 2025.
Impact
HB779 would add a new Section 9-618 to the Correctional Services Article, creating a formal statutory framework for involuntary psychotropic medication decisions in State correctional facilities. It would regulate how prison mental health staff may seek approval to medicate an incarcerated person over objection, establish procedural protections and review rights, and require documentation and periodic reassessment. The bill affects incarcerated individuals receiving mental health treatment, correctional health staff, psychiatrists, and the Department’s internal review structure.
Sentiment
The available record shows no committee transcript, recorded votes, or other public discussion in the provided materials, so there is no documented legislative debate to gauge support or opposition. Based on the bill text, the measure appears to be a departmental/public-safety proposal focused on standardizing mental health treatment procedures and adding due process protections. Its structure suggests an effort to balance clinical authority with procedural safeguards.
Contention
The main potential points of contention are the authority to administer psychotropic medication without consent, the threshold for finding that an incarcerated individual poses a danger to self or others, and whether the committee and administrative review process provide sufficient due process. Additional concerns could include the scope of discretion given to correctional mental health officials, the role of the lay advisor, and the length and renewal of involuntary treatment approvals. Because no transcripts or votes were provided, no specific legislator, agency, or stakeholder objections are documented in the record supplied.